Search Within

Charles Rudin

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (9)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (18)
  2. Department of Medicine (18)
  3. GSK Faculty (18)
  4. Molecular Imaging and Therapy Service (18)
  5. Radiology, Department of (18)
  6. Solid Tumor Oncology Division (18)

More Groups

People
  1. Bob Li (10)
  2. Mark Kris (10)
  3. Michael Offin (9)
  4. Michael Berger (8)
  5. Ronglai Shen (8)
  6. Darren Buonocore (7)

More People

Years
  1. 2024 (3)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Clinical Cancer Research (2)
  3. International Journal of Radiation Oncology, Biology, Physics (2)
  4. Journal of Nuclear Medicine (2)
  5. Annals of Oncology (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (3)
  3. Elsevier Inc. (3)
  4. Elsevier Science, Inc. (2)
  5. Nature Publishing Group (2)
  6. Society of Nuclear Medicine (2)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
    Journal Article

    Korsen, J. A.; Gutierrez, J. A.; Tully, K. M.; Carter, L. M.; Samuels, Z. V.; Khitrov, S.; Poirier, J. T.; Rudin, C. M.; Chen, Y.; Morris, M. J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2022)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • A self-assembling and disassembling (SADA) bispecific antibody (BsAb) platform for curative two-step pretargeted radioimmunotherapy
    Journal Article

    Santich, B. H.; Cheal, S. M.; Ahmed, M.; McDevitt, M. R.; Ouerfelli, O.; Yang, G.; Veach, D. R.; Fung, E. K.; Patel, M.; Burnes Vargas, D.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Self-Assembling and DisAssembling bispecific antibodies for curative 2-step pretargeted radioimmunotherapy
    Meeting Abstract

    Santich, B.; Cheal, S.; Ahmed, M.; McDevitt, M.; Ouerfelli, O.; Veach, D.; Fung, E.; Burnes Vargas, D.; Malik, A.; Guo, H. F.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save